Healthy men test new Drug's safety in early study
NCT ID NCT06816030
First seen Apr 22, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looked at how the body handles MK-4482, an experimental drug, in 16 healthy Chinese men. Participants took single and multiple doses to measure drug levels and check for side effects. The goal was to gather safety and processing data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital (Site 0001)
Beijing, Beijing Municipality, 100191, China
Conditions
Explore the condition pages connected to this study.